Healthcare (TRBC)
NEW YORK (Reuters) - A $117 million verdict against Johnson & Johnson (JNJ.N) and a supplier in favor of a man who said his asbestos-related [more…]
LONDON (Reuters) - Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to [more…]
(Reuters) - Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile [more…]
NEW YORK (Reuters) - Mylan N.V.’s (MYL.O) emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United [more…]
(Reuters) - Kentucky state officials have agreed to hold off enforcing a new law that bans a common abortion procedure from the 11th week of [more…]
(Reuters) - Medical technology company Inogen Inc on Friday disclosed a data breach via an employee email account that resulted in personal information belonging to [more…]
FRANKFURT/NEW YORK (Reuters) - Generic drug maker Mylan (MYL.O) is in advanced discussions to acquire Merck KGaA’s (MRCG.DE) consumer health business after other bidders failed [more…]
(Reuters Health) - Middle-aged men who are sedentary much of the day and don’t get a lot of exercise are more likely to develop bladder [more…]
(Reuters Health) - People who eat lots of processed and red meat are at increased risk of developing chronic liver disease and insulin resistance, a [more…]
(Reuters Health) - Without some kind of health insurance, getting an appointment with a primary care doctor, and being able to pay in full or [more…]
